Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Obese women with PCOS are more likely to have fatty liver disease.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Fat cells are important for tissue repair and stem cell support in various body parts.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Single Blimp1+ cells can create functional sebaceous gland organoids in the lab.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Mobile phone radiation may cause DNA damage in human ear hair follicle cells.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

The pituitary gland functions normally even after losing most SOX2+ stem cells.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Scientists created keratinocyte cell lines from human hair that can differentiate similarly to normal skin cells, offering a new way to study skin biology and diseases.